Application Validation of a Networked Robotic System for Enhanced Bowel and Bladder Care

Research on Intelligent Assessment of Bowel and Bladder Control Ability and Personalized Prescription with Application Validation of a Robotic System, Divided into Two Parts — Integration and Application Validation of a Networked Robotic System for Enhanced Bowel and Bladder Control and Care

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400092918

Enrollment

Unknown

Registered

2024-11-26

Start date

2024-12-01

Completion date

Unknown

Last updated

2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bowel and bladder disfunction

Interventions

Intervention group:(1) Evaluation of the subject's ability to defecate: Enter the subject's relevant information (including medical record number, name, gender, age, height, weight, medical history, d

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Aged >=60 years; 2.Normal mental and cognitive status, able to communicate normally; 3.Currently diagnosed with one of the following conditions: urinary incontinence, constipation, fecal incontinence, or urinary retention, specifically meeting: 1)Urinary Incontinence: Complains of involuntary urine leakage. 2)Constipation: Meets two or more of the following criteria: straining in >25% of bowel movements; >25% of bowel movements are hard or lumpy; >25% of bowel movements feel incomplete; >25% of bowel movements have a sensation of anorectal blockage; manual assistance is needed in >25% of bowel movements; spontaneous bowel movements occur 1 month. 4)Urinary Retention: Complains of incomplete bladder emptying. 4.Voluntarily participates in this study.

Exclusion criteria

Exclusion criteria: 1. severe pelvic organ prolapse; 2. severe cardiovascular and cerebrovascular diseases or other life-threatening diseases; 3. malignant tumours that threaten the patient's life; 4. fistula of the genitourinary tract; 5. previous surgical history of anti-incontinence, urinary retention, fecal incontinence, constipation, and history of medication use. 6. other severe surgical complications.

Design outcomes

Primary

Measure	Time frame
International Consultation on Incontinence Questionnaire - Short Form;Determination of urinary residual volume;Faecal Incontinence Severity Index;Wexner Constipation Scoring System;	—

Secondary

Measure	Time frame
Early warning accuracy;System Usability Scale;Safety of use;Patient compliance;	—

Countries

China

Contacts

Public ContactGong Lichao

Xuanwu Hospital, Capital Medical University

547037728@qq.com+86 153 0002 8979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026